SOND - Bragar Eagel & Squire P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen Sonder QuidelOrtho and Perion Innovations and Encourages Investors to Contact the Firm | Benzinga
NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Ocugen, Inc. (NASDAQ:OCGN), Sonder Holdings Inc. (NASDAQ:SOND), QuidelOrtho Corporation (NASDAQ:QDEL), and Perion Network Ltd. (NASDAQ:PERI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Ocugen, Inc. (NASDAQ:OCGN)
Class Period: May 8, 2020 - April 1, 2024
Lead Plaintiff Deadline: June 10, 2024
According to the filed complaint, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Ocugen's financial statements from May 8, 2020 to the present were materially misstated; (2) Ocugen did not have adequate internal controls; and (3) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times.
For more information on the Ocugen class action go to: https://bespc.com/cases/OCGN
Sonder Holdings Inc. (NASDAQ:SOND)
Class Period: March 16, 2023 - March 15, 2024
Lead Plaintiff Deadline: June 10, 2024
According to the filed complaint, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Sonder failed to disclose all issues with its internal controls; (2) Sonder's financial statements for the 2022 Annual Report and the interim periods ended March 31, June 30, and September 30, 2023 contained material errors in the way Sonder accounted for the valuation and impairment of operating lease right-of-use ("ROU") assets; (3) as a result, Sonder would need to restate its previously issued financial statements for those periods; and (4) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
For more information on the Sonder class action go to: https://bespc.com/cases/SOND
QuidelOrtho Corporation (NASDAQ:QDEL)
Class Period: February 18, 2022 - April 1, 2024 (Common Stock Only)
Lead Plaintiff Deadline: June 11, 2024
QuidelOrtho provides tests for the detection and diagnosis of various respiratory diseases and other medical conditions. The Company's respiratory business has historically ...